Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Micromet awarded grant for genomics-based approach to metastasis

July 24, 1998

Potent activity of orally active antiestrogen EM-800 demonstrated in mice

July 24, 1998

Oncologic Drugs Advisory Committee meets for three days in September

July 22, 1998

Cell Therapeutics licenses rights to PG-TXL

July 22, 1998

Mer-WF-1726: new antitumor substance isolated from natural source

July 22, 1998

Profile of the second-generation alkylphosphocholine perifosine

July 21, 1998

Antimetastatic antibiotic isolated from Penicillium at Takara Shuzo

July 21, 1998

New clinical trial of G-3139 in prostate cancer gets under way at U.S. center

July 21, 1998

Japanese team presents new antitumor anthracyclines

July 20, 1998

Paracelsian and Southern Research Institute to develop new anticancer drugs

July 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.